Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 36.35% is 111% above its 2-year average of -327.70%, near the high end of its 2-year range (-937.64%–85.10%).
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2026 (2026-03-31): -130.54%.
EBITDA MARGIN
36.35%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.46B
EBITDA Margin
3.56%
TTM Avg
3.76%
3Y Avg
3.79%
5Y Avg
3.46%
Market Cap
$1.50B
EBITDA Margin
16.46%
TTM Avg
14.25%
3Y Avg
12.03%
5Y Avg
12.13%
Market Cap
$1.44B
EBITDA Margin
21.45%
TTM Avg
-50.92%
3Y Avg
-538.26%
5Y Avg
-378.46%
Market Cap
$1.52B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | $1.47B | 36.35% | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.48B | 18.52% | 17.87% | 16.34% | 15.57% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 3.56% | 3.76% | 3.79% | 3.46% |
| GH Research PLC (GHRS)vs › | $1.50B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 16.46% | 14.25% | 12.03% | 12.13% |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 21.45% | -50.92% | -538.26% | -378.46% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 5.15% | 0.72% | -7.50% | -11313.48% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.42B | -10195.54% | -87388.52% | -48181.08% | -32386.50% |
Gross Margin
0.0%
EBITDA Margin
36.4%
Operating Margin
0.0%
Net Margin
-668.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | -130.54% |
| 2024-09-30 | -937.64% |
| 2024-06-30 | 85.10% |
